Advances in pancreatic neuroendocrine tumor treatment. (Record no. 20824466)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01245 a2200337 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516035241.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201106s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1533-4406 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1056/NEJMc1102746 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | van der Veldt, Astrid A M |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20110601 |
245 00 - TITLE STATEMENT | |
Title | Advances in pancreatic neuroendocrine tumor treatment. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The New England journal of medicine |
Date of publication, distribution, etc. | 05 2011 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1873; author reply 1873-5 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Letter; Comment |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Blood Glucose |
General subdivision | analysis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Diabetes Complications |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Everolimus |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Indoles |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neuroendocrine Tumors |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pancreatic Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrroles |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sirolimus |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sunitinib |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kleijn, Sebastiaan A |
773 0# - HOST ITEM ENTRY | |
Title | The New England journal of medicine |
Related parts | vol. 364 |
-- | no. 19 |
-- | p. 1873; author reply 1873-5 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1056/NEJMc1102746">https://doi.org/10.1056/NEJMc1102746</a> |
Public note | Available from publisher's website |
No items available.